Cargando…

The SINS trial: A randomised controlled trial of excisional surgery versus imiquimod 5% cream for nodular and superficial basal cell carcinoma

BACKGROUND: Basal cell carcinoma is the commonest human cancer. Despite increasing incidence it remains poorly researched. While not life threatening it can cause significant cosmetic disfigurement. Imiquimod, a cream which enhances the body's immune response, may help deal with the number of c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ozolins, Mara, Williams, Hywel C, Armstrong, Sarah J, Bath-Hextall, Fiona J
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Study protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2877028/ https://www.ncbi.nlm.nih.gov/pubmed/20409337 http://dx.doi.org/10.1186/1745-6215-11-42

Ejemplares similares

What determines patient preferences for treating low risk basal cell carcinoma when comparing surgery vs imiquimod? A discrete choice experiment survey from the SINS trial
por: Tinelli, Michela, et al.
Publicado: (2012)

Imiquimod cream efficacy in the treatment of periocular nodular basal cell carcinoma: a non-randomized trial
por: Macedo, Erick Marcet Santiago de, et al.
Publicado: (2015)

Imiquimod 5% cream for the treatment of large nodular basal cell carcinoma at the medial canthal area
por: Karabulut, Gamze Ozturk, et al.
Publicado: (2017)

Reflectance Confocal Microscopy Follow-up of Multifocal Superficial Basal Cell Carcinomas Treated With Imiquimod 5% Cream
por: Zou, Yunmin, et al.
Publicado: (2022)

Disseminated Superficial Actinic Porokeratosis on the Face Treated with Imiquimod 5% Cream
por: Riad, Hassan, et al.
Publicado: (2013)

Imiquimod (Aldara cream).
por: Buck, H W
Publicado: (1998)

Management of superficial basal cell carcinoma: focus on imiquimod
por: Raasch, Beverly
Publicado: (2009)

Superficial Basal Cell Carcinoma on the Back Region Treated with a Combination of Cryotherapy and 5% Imiquimod Cream: A Case Report
por: Sutedja, Eva Krishna, et al.
Publicado: (2023)

PIGMENTED BASAL CELL CARCINOMA SUCCESSFULLY TREATED WITH 5% IMIQUIMOD CREAM
por: Mehta, Vandana, et al.
Publicado: (2008)

Facial Basal Cell Carcinoma Treated with Topical 5% Imiquimod Cream with Dermoscopic Evaluation
por: Singal, Archana, et al.
Publicado: (2016)

Line-Field Confocal Optical Coherence Tomography May Enhance Monitoring of Superficial Basal Cell Carcinoma Treated with Imiquimod 5% Cream: A Pilot Study
por: Verzì, Anna Elisa, et al.
Publicado: (2021)

The Importance of Excisional Biopsy in Nodular Lymphocyte-Predominant Hodgkin’s Lymphoma
por: Juarez, Angel, et al.
Publicado: (2023)

Efficacy and safety of electronic brachytherapy for superficial and nodular basal cell carcinoma
por: Ballester-Sánchez, Rosa, et al.
Publicado: (2015)

Comparison of Conservative Treatment of Cervical Intraepithelial Lesions with Imiquimod with Standard Excisional Technique Using LLETZ: A Randomized Controlled Trial
por: Cokan, Andrej, et al.
Publicado: (2021)

GENITAL VITILIGO FOLLOWING USE OF IMIQUIMOD 5% CREAM
por: Zhang, Ruzhi, et al.
Publicado: (2011)

Treatment of Cutaneous Tumors with Topical 5% Imiquimod Cream
por: Alessi, Sabrina Sisto, et al.
Publicado: (2009)

Successful Treatment of Giant Basal Cell Carcinoma with Topical Imiquimod 5% Cream with Long Term Follow-up
por: Chun-Guang, M, et al.
Publicado: (2014)

Risk factors in Central Poland for the development of superficial and nodular basal cell carcinomas
por: Lesiak, Aleksandra, et al.
Publicado: (2010)

Electronic brachytherapy for superficial and nodular basal cell carcinoma: a report of two prospective pilot trials using different doses
por: Ballester-Sánchez, Rosa, et al.
Publicado: (2016)

Treatment of Keratoacanthoma with 5% Imiquimod Cream and Review of the Previous Report
por: Jeon, Hye Chan, et al.
Publicado: (2011)

Imiquimod 5% as Adjuvant Therapy for Incompletely Excised Infiltrative Nodular Basal Cell Carcinoma and Dermoscopy to Monitor Treatment Response
por: Roldán-Marín, Rodrigo, et al.
Publicado: (2015)

Human papillomavirus infection: protocol for a randomised controlled trial of imiquimod cream (5%) versus podophyllotoxin cream (0.15%), in combination with quadrivalent human papillomavirus or control vaccination in the treatment and prevention of recurrence of anogenital warts (HIPvac trial)
por: Murray, Macey L., et al.
Publicado: (2018)

Erythroplasia of Queyrat treated with imiquimod 5% cream: The necessity of regimen guidelines
por: Yokoyama, Maiko, et al.
Publicado: (2019)

Perianal Basal Cell Carcinoma Successfully Managed with Excisional Biopsy
por: Aldana, Paola C., et al.
Publicado: (2019)

Curettage vs. cryosurgery for superficial basal cell carcinoma: a prospective, randomised and controlled trial
por: Backman, E.J., et al.
Publicado: (2022)

Kaposi's sarcoma responding to topical imiquimod 5% cream: a case report
por: Benomar, Sophia, et al.
Publicado: (2009)

Efficacy of 5% Imiquimod Cream on Vulvar Intraepithelial Neoplasia in Korea: Pilot Study
por: Kim, Jeong-Min, et al.
Publicado: (2015)

Early Treatment with Imiquimod 5% Cream of Periungual Warts in Vietnam: The Poorer, the Better
por: Minh, Phuong Pham Thi, et al.
Publicado: (2019)

Vitiligo-Like Depigmentation following Treatment with Imiquimod 5% Cream for Condylomata Acuminata
por: Alatabani, Maram, et al.
Publicado: (2021)

Immune-mediated changes in actinic keratosis following topical treatment with imiquimod 5% cream
por: Torres, Abel, et al.
Publicado: (2007)

Visualization and Treatment of Subclinical Actinic Keratoses with Topical Imiquimod 5% Cream: An Observational Study
por: Kopera, Daisy, et al.
Publicado: (2014)

Elastosis Perforans Serpiginosa in a patient with Down syndrome treated with imiquimod 5% cream
por: Gregersen, Pernille Axél, et al.
Publicado: (2010)

Therapeutic Efficacies of Artemisia capillaris Extract Cream Formulation in Imiquimod-Induced Psoriasis Models
por: Lee, Song Yi, et al.
Publicado: (2018)

Long-Term Follow-Up of Lentigo Maligna Patients Treated with Imiquimod 5% Cream
por: Seyed Jafari, S. Morteza, et al.
Publicado: (2023)

A cutback in Imiquimod cutaneous toxicity; comparative cutaneous toxicity analysis of Imiquimod nanotransethosomal gel with 5% marketed cream on the BALB/c mice
por: Jamshaid, Humzah, et al.
Publicado: (2022)

Pharmacology education for nurse prescribing students – a lesson in reusable learning objects
por: Lymn, Joanne S, et al.
Publicado: (2008)

Teaching tools in Evidence Based Practice: evaluation of reusable learning objects (RLOs) for learning about Meta-analysis
por: Bath-Hextall, Fiona, et al.
Publicado: (2011)

Effect of adjuvant imiquimod 5% cream on sustained clearance of anogenital warts following laser treatment.
por: Hoyme, U B, et al.
Publicado: (2002)

Effective Combination of Photodynamic Therapy and Imiquimod 5% Cream in the Treatment of Actinic Keratoses: Three Cases
por: Held, Laura, et al.
Publicado: (2013)

Development of Vitiligo-Like Depigmentation after Treatment of Lentigo Maligna Melanoma with 5% Imiquimod Cream
por: Kim, Na Hee, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_mjd00hhb69hnj7qjrrlha61ajc